Suppr超能文献

鉴定一种减数分裂特异性蛋白为癌胚抗原类的成员。

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens.

作者信息

Türeci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M

机构信息

Medizinische Klinik I, Universitätskliniken des Saarlandes, 66421 Homburg/Saar, Germany.

出版信息

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5211-6. doi: 10.1073/pnas.95.9.5211.

Abstract

Little is known about the function of human cancer/testis antigens (CTAs), such as MAGE, BAGE, GAGE, HOM-MEL-40, and NY-ESO-1, the expression of which is restricted to human malignancies and testis. When screening a cDNA expression library enriched for testis-specific representative long transcripts for reactivity with high-titered IgG antibodies from the serum of a patient with renal cell carcinoma, one repeatedly detected antigen, designated HOM-TES-14, turned out to be encoded by the synaptonemal complex protein 1 (SCP-1) gene. SCP-1 is known to be selectively expressed during the meiotic prophase of spermatocytes and is involved in the pairing of homologous chromosomes, an essential step for the generation of haploid cells in meiosis I. Investigation of a broad spectrum of normal and malignant tissues revealed expression of SCP-1 transcripts and antigen selectively in a variety of neoplastic tissues and tumor cell lines. Immunofluorescence microscopy analysis with specific antiserum showed a cell cycle phase-independent nuclear expression of SCP-1 protein in cancer cells. SCP-1 differs from other members of the class of CTA by its localization on chromosome 1 and its frequent expression in malignant gliomas, breast, renal cell, and ovarian cancer. The aberrant expression of SCP-1 in tumors might contribute to their genomic instability and suggests that the functional role of other CTA might also relate to meiosis.

摘要

对于人类癌胚抗原(CTA),如黑色素瘤抗原(MAGE)、癌胚抗原(BAGE)、肿瘤相关抗原(GAGE)、同源黑色素瘤-40(HOM-MEL-40)和纽约食管鳞状细胞癌-1(NY-ESO-1)的功能知之甚少,这些抗原的表达仅限于人类恶性肿瘤和睾丸。在用来自一名肾细胞癌患者血清的高滴度IgG抗体筛选富含睾丸特异性代表性长转录本的cDNA表达文库时,一种反复检测到的抗原,命名为HOM-TES-14,结果发现是由联会复合体蛋白1(SCP-1)基因编码的。已知SCP-1在精母细胞减数分裂前期选择性表达,并参与同源染色体配对,这是减数分裂I中产生单倍体细胞的关键步骤。对广泛的正常和恶性组织进行研究发现,SCP-1转录本和抗原在多种肿瘤组织和肿瘤细胞系中选择性表达。用特异性抗血清进行免疫荧光显微镜分析显示,癌细胞中SCP-1蛋白的表达与细胞周期阶段无关。SCP-1与CTA类的其他成员不同,其定位于1号染色体,且在恶性胶质瘤、乳腺癌、肾细胞癌和卵巢癌中频繁表达。SCP-1在肿瘤中的异常表达可能导致其基因组不稳定,这表明其他CTA的功能作用也可能与减数分裂有关。

相似文献

引用本文的文献

5
Meiotic Genes and DNA Double Strand Break Repair in Cancer.减数分裂基因与癌症中的DNA双链断裂修复
Front Genet. 2022 Feb 18;13:831620. doi: 10.3389/fgene.2022.831620. eCollection 2022.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验